Press release
Cytokine Market Global Report 2022-2027: Industry Size, Share, Trends, Growth and Forecast
The latest research study "Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global cytokine market size reached US$ 76.67 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 121.25 Billion by 2027 exhibiting a CAGR of 7.80% during 2022-2027.Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Download free sample brochure: https://www.imarcgroup.com/cytokine-market/requestsample
Industry Definition and Application:
Cytokine is a class of proteins, peptides, or glycoproteins produced by specific cells that regulate the growth and activity of other blood and immune system cells. Since it has high-affinity picomolar concentrations, it helps control immunity, inflammation, and hematopoiesis. It is usually injected into veins, muscles, or under the skin to treat cancer and prevent or manage chemotherapy side effects. In recent years, cytokine has gained immense traction in immune cell differentiation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis as it acts as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases.
Cytokine Market Trends and Drivers:
The global cytokine market is primarily driven by the recent outbreak of the coronavirus disease (Covid-19), which induces the excessive production of pro-inflammatory cytokines resulting in tissue damage and acute respiratory distress syndrome (ARDS) aggravation. This has strengthened the need for solutions that target cytokines for better patient management, improved survival rates, and reduced mortality, as tissue damage can lead to multiple organ failures and even death.
Additionally, there has been a significant shift toward minimally invasive surgeries (MIS) due to their faster recovery time and lesser post-operative pain and complications. In line with this, the surging prevalence of atopic dermatitis (AD), a chronic, inflammatory, and recurring skin disease, has catalyzed the demand for new cytokines in the pathogenesis of AD and the development of improved therapeutic targets.
Other factors, including the rising incidences of cancer and skin disorders, ongoing research and development (R&D) activities, and continual technological advancements, are also anticipated to propel the market growth.
Click here to view detailed information with table of content: https://www.imarcgroup.com/cytokine-market
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Cytokine Type:
• Tumor Necrosis Factor-TNF
• Interleukins-Il
• Interferons-IFN
• Epidermal Growth Factor-EGF
• Others
Breakup by Therapeutic Application:
• Cancer
• Asthma and Airway Inflammation
• Arthritis
• Others
Breakup by End User:
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic and Research Institutes
Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa
List of Major Key Players:
The major players in the market are AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.
Also, Read Latest Research Reports by IMARC Group:
Residential Washing Machine Market Report: https://www.imarcgroup.com/residential-washing-machine-market
Location-Based Services (LBS) Market Forecast: https://www.imarcgroup.com/location-based-services-market
Food Coating Ingredients Market Trend 2022-27: https://www.imarcgroup.com/food-coating-ingredients-market
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cytokine Market Global Report 2022-2027: Industry Size, Share, Trends, Growth and Forecast here
News-ID: 2708585 • Views: …
More Releases from IMARC Group
Hexene Production Plant Setup Cost in 2026: Equipment, Raw Materials, and Invest …
IMARC's new report titled "Hexene Production Cost Analysis Report 2026: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue," provides a complete roadmap for setting up a Hexene production plant. The study covers all the requisite aspects one needs to know while entering the Hexene industry. It offers a comprehensive breakdown of the Hexene production plant setup cost, providing detailed insights into initial capital requirements and infrastructure…
Mexico In-Vitro Diagnostics Market Size, Share, Industry Trends, Growth Factors …
IMARC Group has recently released a new research study titled "Mexico In-Vitro Diagnostics Market Report by Test Type (Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, and Others), Product (Reagents and Kits, Instruments), Usability (Disposable IVD Devices, Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others), End User (Hospitals Laboratories, Clinical Laboratories, Point-of-care Testing Centers, Academic Institutes, Patients, and Others), and Region 2025-2033", offers a detailed analysis…
Bamboo Paper Plant Setup 2025: CAPEX Breakdown & Machinery Sourcing Guide
Bamboo paper is an eco-friendly paper product manufactured using bamboo pulp instead of traditional wood pulp. Bamboo grows rapidly, requires minimal water and chemicals, and regenerates naturally, making it a highly sustainable raw material for the paper industry. Bamboo paper is widely used in printing and writing paper, tissue paper, packaging materials, notebooks, and specialty paper products, offering good strength, smooth texture, and reduced environmental impact compared to conventional paper.
Setting…
Interlocking Paver Blocks Manufacturing Plant Report 2025: Setup Details, Capita …
Interlocking paver blocks are precast concrete paving units designed to interlock with each other, forming a durable and flexible pavement surface. Manufactured using cement, aggregates, sand, and pigments, these blocks are widely used in driveways, walkways, parking areas, industrial floors, roads, and landscaping projects. Their high load-bearing capacity, aesthetic appeal, easy maintenance, and long service life make interlocking paver blocks a preferred alternative to conventional asphalt and concrete pavements.
Setting up…
More Releases for Cytokine
Cytokine Release Syndrome Market New Product Development & Latest Trends
Introduction
Cytokine release syndrome (CRS) is a systemic inflammatory response triggered by an excessive activation of the immune system, leading to a surge of pro-inflammatory cytokines. While CRS can occur in severe infections and autoimmune conditions, it has gained heightened significance as a common and potentially life-threatening complication of advanced immunotherapies, particularly chimeric antigen receptor T-cell (CAR-T) therapy, bispecific antibodies, and immune checkpoint inhibitors.
Symptoms range from fever, hypotension, and hypoxia to…
Cytokine Release Syndrome Management Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Cytokine Release Syndrome Management Market - (By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF), By Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), By Biomarker Type (Interleukin-10, Interleukin-6, Ferritin, Cluster of Differentiation-163), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast…
Emerging Trends Influencing The Growth Of The Cytokine Release Syndrome Treatmen …
The Cytokine Release Syndrome Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Cytokine Release Syndrome Treatment Market Size Expected to Be by 2034?
The market size for the treatment of cytokine release syndrome has experienced remarkable growth recently. The market value…
Cytokine Release Syndrome Management Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Cytokine Release Syndrome Management Market - (By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF), By Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), By Biomarker Type (Interleukin-10, Interleukin-6, Ferritin, Cluster of Differentiation-163), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast…
Key Driver Shaping the Future Cytokine Release Syndrome Treatment Market From 20 …
What Is the Estimated Market Size and Growth Rate for the Cytokine Release Syndrome Treatment Market?
In recent times, the market size for treatments of cytokine release syndrome has seen a rapid increase. The forecast predicts an upsurge from $1.25 billion in 2024 to $1.42 billion in 2025, presenting a compound annual growth rate (CAGR) of 13.7%. A growth surge during the historical period can be credited to factors such as…
Cytokine Market Size, Share, Growth Report and Forecast 2024-2032
According to the report by Expert Market Research (EMR), the global cytokine market is projected to grow at a CAGR of 6% between 2024 and 2032. Aided by the burgeoning applications in medical and research fields, the market is expected to grow significantly by 2032.
Cytokines are a broad category of small proteins that are crucial in cell signalling. Their role is primarily related to immune and inflammatory responses. These proteins…
